1.All
Pre-IRE vs 1 week post
Pre-IRE vs 4 weeks post
1 week - vs 4 weeks post
EPIC uro
0.01*
0.01*
0.86
EPIC bowel
0.72
0.57
0.43
EPIC sex
0.54
0.17
0.03*
EPIC hor
0.31
0.65
0.39
IPSS QoL
0.14
0.19
0.02*
IPSS
0.37
0.53
0.75
IIEF
0.71
1.00
0.95
Qmax
0.11
0.05
0.28
Residu
0.11
0.13
0.66
2. Extended
Pre-IRE vs 1 week post
Pre-IRE vs 4 weeks post
1 week-vs 4 weeks post
EPIC uro
0.02*
0.04*
0.37
EPIC bowel
0.87
0.83
0.67
EPIC sex
0.17
0.44
0.03*
EPIC hor
0.25
0.21
0.71
IPSS QoL
0.26
0.30
0.08
IPSS
0.55
0.48
0.39
IIEF
0.80
0.61
0.28
Qmax
0.67
0.21
0.67
Residu
0.07
0.16
0.14
3. Focal
Pre-IRE vs 1 week post
Pre-IRE vs 4 weeks post
1 week- vs 4 weeks post
EPIC uro
0.17
0.08
0.46
EPIC bowel
0.65
0.18
0.16
EPIC sex
0.75
0.35
0.79
EPIC hor
0.58
0.47
0.46
IPSS QoL
0.16
0.40
0.10
IPSS
0.50
0.90
0.60
IIEF
0.89
0.34
0.20
Qmax
0.05
0.01*
0.10
Residu
0.70
1.00
0.29
Pre-IRE vs day 0
Pre-IRE vs 1 day
Pre-IRE vs 1 week
Pre-IRE vs 4 week
VAS All
0.01*
0.01*
0.06
0.18
VAS Focal
0.07
0.07
1.00
1.00
VAS Extended
0.07
0.07
0.06
0.18
Table 5:
P-values of Wilcoxon signed rank-test for all patients (1), extended treatment group (2), focal treatment group (3).
